Explore how proteomics transforms pharmaceutical R&D, from drug discovery to biomarker qualification and clinical development ...
Explore how proteomics in cancer research advances tumor profiling, biomarker discovery, and precision oncology workflows.
MI-Common Data Model: Extending Observational Medical Outcomes Partnership-Common Data Model (OMOP-CDM) for Registering Medical Imaging Metadata and Subsequent Curation Processes The Osteosarcoma ...
Comprehensive Genomic Assessment of Advanced-Stage GI Stromal Tumors Using the Japanese National Center for Cancer Genomics and Advanced Therapeutics Database We analyzed the genomic and immune ...